Interferon beta treatment in relapsing-remitting multiple sclerosis: A post-marketing study in Lombardia, Italy

Italian Journal of Neurological Sciences

Volumn 20, Issue 5, 1999, Pages 297-302

  Milanese, C ^a   La Mantia, L ^a   Palumbo, R ^a  

^a DEPARTMENT OF NEUROSURGERY   (Italy)

Author keywords

Avonex; Betaferon; Interferon beta; Multiple sclerosis

Indexed keywords

BETA1A INTERFERON; INTERFERON BETA SERINE;

ADULT; ARTICLE; CLINICAL PRACTICE; DRUG EFFICACY; FEMALE; HUMAN; ITALY; MAJOR CLINICAL STUDY; MALE; MULTIPLE SCLEROSIS; PATIENT MONITORING; TREATMENT OUTCOME;

EID: 0033497444     PISSN: 03920461     EISSN: None     Source Type: Journal    
DOI: 10.1007/s100720050044     Document Type: Article

References (10)

1. -(l996) Autorizzazione alla immissione in commercio della spécialité médicinale Betaferon. Décréta Ministeriale del 5 febbraio 1996. Gazzetta Ufficiale, n. 41 of 19 February 1996
2. -(1997) Autorizzazione alla immissione in commercio della specialità médicinale Avonex. Décréta Ministeriale dell'8 agosto 1997. Gazzetta Ufficiale, n. 186 of 11 August 1997
3. Goodkin DE, Kanoti G (1994) Ethical considerations raised by the approval of interferon beta-lb for the treatment of multiple sclerosis. Neurology 44:166-170
4. Poser CM, Paty DW, Scheinberg L et al (1983) New diag-nostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 12:227-231
5. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444-1452
6. The IFNB Multiple Sclerosis Study Group (1993) Interferon beta-lb is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized double-blind, placebo-controlled trial. Neurology 43:655-661
7. The IFNB Multiple Sclerosis Study Group and the Universisy of British Columbia MS/MRI Analysis Group (1995) Interferon beta-lb in the treatment of multiple sclerosis: final outcome of the randomized controlled trial. Neurology 45:1277-1285
8. Jacobs LD, Cookfair DL, Rudick RA et al (1996) Intramuscular Interferon beta-1 a for disease progression in relapsing multiple sclerosis. Ann Neurol 39:285-294
9. Huber S, Spycher M, Lechner-Scott J et al (1996) Therapie mit rekombinantem Interferon beta-lb. Schweiz Med Wochenschr 126:1475-1481
10. Multiple Sclerosis Study Group of the City of Valencia (1997) Interferon beta-lb in the treatment of relapsing-recurrent multiple sclerosis. Clinical experience of the Valencia group. Revista de Neurologia 25:1876-1879